Michael Cohenuram, MD in Danbury, CT - Medicare Hematology/oncology

Michael Cohenuram, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Danbury, Connecticut. He went to Icahn School Of Medicine At Mount Sinai and graduated in 2000 and has 24 years of diverse experience with area of expertise as Hematology/oncology. He is a member of the group practice Rehabilitation Associates Inc, Yale University and his current practice location is 24 Hospital Ave, Danbury, Connecticut. You can reach out to his office (for appointments etc.) via phone at (203) 797-7742.

Michael Cohenuram is licensed to practice in Connecticut (license number 045754) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1043409691.

Contact Information

	Michael Cohenuram, MD
	24 Hospital Ave, Danbury, CT 06810-6099
	(203) 797-7742
	(203) 830-2090

Physician's Profile

Full Name	Michael Cohenuram
Gender	Male
Speciality	Hematology/oncology
Experience	24 Years
Location	24 Hospital Ave, Danbury, Connecticut
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Michael Cohenuram attended and graduated from Icahn School Of Medicine At Mount Sinai in 2000

NPI Data:

NPI Number: 1043409691
Provider Enumeration Date: 10/19/2007
Last Update Date: 10/19/2007

Medicare PECOS Information:

PECOS PAC ID: 5193709525
Enrollment ID: I20080707000615

Medical Identifiers

Medical identifiers for Michael Cohenuram such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1043409691	NPI	-	NPPES
045754	Other	CT	MEDICAL LICENSE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RH0003X	Internal Medicine - Hematology & Oncology	045754 (Connecticut)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Yale-new Haven Hospital	New haven, CT	Hospital
Bridgeport Hospital	Bridgeport, CT	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Rehabilitation Associates Inc	8022905322	297
Yale University	9436061736	2241

News Archive

Study finds that 94% of air travelers would want health authorities to contact them if they have been exposed to a serious contagious disease on an airplane

A new study by the Harvard School of Public Health Project on the Public and Biological Security finds that the vast majority (94%) of air travelers would want public health authorities to contact them if they might have been exposed to a serious contagious disease on an airplane.

Altherx Pharmaceuticals receives U.S. patent for use of solabegron for treatment of overactive bladder

AltheRx Pharmaceuticals, a privately-held clinical development company, today announced the United States Patent and Trademark Office issued a Notice of Allowance for the company's U.S. Patent Application claiming a method of use for solabegron, a beta 3-adrenergic receptor agonist, in combination with all commercially available antimuscarinics at both therapeutic and sub-therapeutic doses for the treatment of overactive bladder (OAB).

Multivitamin disappoints in first long-term CV trial

Taking a daily multivitamin does not reduce the risk for major cardiovascular events or mortality in men, research suggests.

FDA grants orphan drug designation to pralatrexate for treatment of advanced TCC of urinary bladder

Allos Therapeutics, Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to pralatrexate for the treatment of advanced or metastatic transitional cell carcinoma of the urinary bladder, a form of bladder cancer. The Company is currently investigating pralatrexate in a Phase 2 clinical study in patients with advanced or metastatic relapsed TCC of the urinary bladder.

IRIS International announces the launch of new and improved corporate website

IRIS International, Inc., a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, announced today the launch of its new and improved corporate website at www.proiris.com, featuring a newly designed homepage and enhanced navigation tools with access to the latest company information.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Michael Cohenuram allows following entities to bill medicare on his behalf.

Entity Name	Yale University
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015

News Archive

Study finds that 94% of air travelers would want health authorities to contact them if they have been exposed to a serious contagious disease on an airplane

Altherx Pharmaceuticals receives U.S. patent for use of solabegron for treatment of overactive bladder

Multivitamin disappoints in first long-term CV trial

Taking a daily multivitamin does not reduce the risk for major cardiovascular events or mortality in men, research suggests.

FDA grants orphan drug designation to pralatrexate for treatment of advanced TCC of urinary bladder

IRIS International announces the launch of new and improved corporate website

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michael Cohenuram is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Michael Cohenuram, MD 24 Hospital Ave, Danbury, CT 06810-6099 Ph: (203) 797-7742	Michael Cohenuram, MD 24 Hospital Ave, Danbury, CT 06810-6099 Ph: (203) 797-7742

News Archive

Study finds that 94% of air travelers would want health authorities to contact them if they have been exposed to a serious contagious disease on an airplane

Altherx Pharmaceuticals receives U.S. patent for use of solabegron for treatment of overactive bladder

Multivitamin disappoints in first long-term CV trial

Taking a daily multivitamin does not reduce the risk for major cardiovascular events or mortality in men, research suggests.

FDA grants orphan drug designation to pralatrexate for treatment of advanced TCC of urinary bladder

IRIS International announces the launch of new and improved corporate website

Internal Medicine Doctors in Danbury, CT

Dr. Shivayogi V Magavi, MD Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 57 North St, Suite 103, Danbury, CT 06810 Phone: 203-744-7007
Andrew Keller, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 27 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7155
Mary E. Blackman, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 79 Sand Pit Road, 102, Danbury, CT 06810 Phone: 203-749-5700
Nirmalamma S Magavi, MD Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 57 North St, Suite 103, Danbury, CT 06810 Phone: 203-744-7007
David D Weinshel, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7173
Dr. Michael Spiegel, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 33 Germantown Rd, 1st Floor, Danbury, CT 06810 Phone: 203-794-5600 Fax: 203-794-5611

Michael Cohenuram, MD - Medicare Hematology/oncology in Danbury, CT

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Study finds that 94% of air travelers would want health authorities to contact them if they have been exposed to a serious contagious disease on an airplane

Altherx Pharmaceuticals receives U.S. patent for use of solabegron for treatment of overactive bladder

Multivitamin disappoints in first long-term CV trial

FDA grants orphan drug designation to pralatrexate for treatment of advanced TCC of urinary bladder

IRIS International announces the launch of new and improved corporate website

Medicare Reassignments

Study finds that 94% of air travelers would want health authorities to contact them if they have been exposed to a serious contagious disease on an airplane

Altherx Pharmaceuticals receives U.S. patent for use of solabegron for treatment of overactive bladder

Multivitamin disappoints in first long-term CV trial

FDA grants orphan drug designation to pralatrexate for treatment of advanced TCC of urinary bladder

IRIS International announces the launch of new and improved corporate website

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Study finds that 94% of air travelers would want health authorities to contact them if they have been exposed to a serious contagious disease on an airplane

Altherx Pharmaceuticals receives U.S. patent for use of solabegron for treatment of overactive bladder

Multivitamin disappoints in first long-term CV trial

FDA grants orphan drug designation to pralatrexate for treatment of advanced TCC of urinary bladder

IRIS International announces the launch of new and improved corporate website

Internal Medicine Doctors in Danbury, CT